Combinations of growth factors for human mesenchymal stem cell proliferation and osteogenic differentiation.

Growth factor Mesenchymal stem cell Osteogenic differentiation Regenerative medicine

Journal

Bone & joint research
ISSN: 2046-3758
Titre abrégé: Bone Joint Res
Pays: England
ID NLM: 101586057

Informations de publication

Date de publication:
Jul 2020
Historique:
entrez: 1 9 2020
pubmed: 31 8 2020
medline: 31 8 2020
Statut: epublish

Résumé

Here we introduce a wide and complex study comparing effects of growth factors used alone and in combinations on human mesenchymal stem cell (hMSC) proliferation and osteogenic differentiation. Certain ways of cell behaviour can be triggered by specific peptides - growth factors, influencing cell fate through surface cellular receptors. In our study transforming growth factor β (TGF-β), basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), insulin-like growth factor 1 (IGF-1), and vascular endothelial growth factor (VEGF) were used in order to induce osteogenesis and proliferation of hMSCs from bone marrow. These cells are naturally able to differentiate into various mesodermal cell lines. Effect of each factor itself is pretty well known. We designed experimental groups where two and more growth factors were combined. We supposed cumulative effect would appear when more growth factors with the same effect were combined. The cellular metabolism was evaluated using MTS assay and double-stranded DNA (dsDNA) amount using PicoGreen assay. Alkaline phosphatase (ALP) activity, as early osteogenesis marker, was observed. Phase contrast microscopy was used for cell morphology evaluation. TGF-β and bFGF were shown to significantly enhance cell proliferation. VEGF and IGF-1 supported ALP activity. Light microscopy showed initial extracellular matrix mineralization after VEGF/IGF-1 supply. A combination of more than two growth factors did not support the cellular metabolism level and ALP activity even though the growth factor itself had a positive effect. This is probably caused by interplay of various messengers shared by more growth factor signalling cascades.Cite this article:

Identifiants

pubmed: 32864112
doi: 10.1302/2046-3758.97.BJR-2019-0183.R2
pii: BJR-9-412
pmc: PMC7437520
doi:

Types de publication

Journal Article

Langues

eng

Pagination

412-420

Informations de copyright

© 2020 Author(s) et al.

Références

J Biol Chem. 2002 Sep 27;277(39):36024-31
pubmed: 12130649
Cell Tissue Res. 2012 Jun;348(3):475-84
pubmed: 22437875
J Bone Miner Metab. 2014 Nov;32(6):627-35
pubmed: 24306516
Clin Orthop Relat Res. 1991 Feb;(263):30-48
pubmed: 1993386
Int J Endocrinol. 2014;2014:235060
pubmed: 25147565
J Cell Mol Med. 2012 Jun;16(6):1260-73
pubmed: 21831134
Gene. 2012 Apr 25;498(1):1-4
pubmed: 22342254
BMC Dev Biol. 2014 May 18;14:21
pubmed: 24886313
Bone Joint Res. 2019 Sep 3;8(8):397-404
pubmed: 31537997
Int J Biol Sci. 2012;8(2):272-88
pubmed: 22298955
Stem Cell Res Ther. 2010 Oct 26;1(4):32
pubmed: 20977782
Curr Rheumatol Rep. 2003 Jun;5(3):222-6
pubmed: 12744815
Tissue Eng Part A. 2010 Jul;16(7):2295-306
pubmed: 20184436
J Biol Chem. 2011 Nov 25;286(47):40575-83
pubmed: 21987573
Bone Joint J. 2019 Apr;101-B(4):361-364
pubmed: 30929493
Cold Spring Harb Perspect Biol. 2017 Aug 1;9(8):
pubmed: 28130363
Genes Dev. 2006 Mar 15;20(6):666-74
pubmed: 16543220
J Nippon Med Sch. 2010 Feb;77(1):4-12
pubmed: 20154452
Biol Cell. 2009 Sep;101(9):525-39
pubmed: 19281453
Bone Joint Res. 2017 May;6(5):277-283
pubmed: 28473335
Mol Endocrinol. 2014 May;28(5):722-30
pubmed: 24673557
Biomol Eng. 2007 Dec;24(6):613-8
pubmed: 17936069
Blood Cells Mol Dis. 2001 May-Jun;27(3):677-90
pubmed: 11482883
Acta Biomater. 2011 Feb;7(2):463-77
pubmed: 20688199
Blood. 2007 Apr 1;109(7):3024-30
pubmed: 17138824
ASAIO J. 2007 Mar-Apr;53(2):219-28
pubmed: 17413564
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1292-6
pubmed: 21129279
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
Amino Acids. 2014 Jul;46(7):1673-80
pubmed: 24677149
Future Sci OA. 2016 Sep 22;2(4):FSO142
pubmed: 28116125
Acta Chir Orthop Traumatol Cech. 2011;78(2):138-44
pubmed: 21575557
Bone. 2015 Nov;80:14-18
pubmed: 26453494
Springerplus. 2014 Feb 11;3:80
pubmed: 24570851
Tissue Eng. 2005 Jan-Feb;11(1-2):41-9
pubmed: 15738660
Biochim Biophys Acta Gen Subj. 2019 Jan;1863(1):199-209
pubmed: 30312769
Expert Opin Ther Targets. 2016 Sep;20(9):1087-98
pubmed: 26941128
Dev Dyn. 2017 Apr;246(4):227-234
pubmed: 27750398
Bone Joint Res. 2019 Aug 2;8(7):323-332
pubmed: 31463041
Growth Factors. 2003 Jun;21(2):87-94
pubmed: 14626356
Stem Cell Res. 2012 May;8(3):346-56
pubmed: 22286010
Biochim Biophys Acta. 2009 Dec;1790(12):1592-8
pubmed: 19786074
Cytokine. 2010 Sep;51(3):305-10
pubmed: 20580248
Front Bioeng Biotechnol. 2017 Nov 03;5:68
pubmed: 29164110

Auteurs

Veronika Hefka Blahnova (V)

Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czech Republic.
Second Faculty of Medicine, Charles University, Prague, Czech Republic.

Jana Dankova (J)

Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czech Republic.

Michala Rampichova (M)

Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czech Republic.

Eva Filova (E)

Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czech Republic.
Second Faculty of Medicine, Charles University, Prague, Czech Republic.

Classifications MeSH